There are currently 13 active clinical trials seeking participants for Celiac Disease research studies. The states with the highest number of trials for Autism participants are California, Florida, Texas and Massachusetts.
General Population Level Estimation for Type 1 Diabetes Risk in Children During Routine Care Delivery
NCT04477928
Recruiting
In partnership with Helmsley Charitable Trust, the Sanford PLEDGE Study is a large-scale, observational, feasibility study of general population screening for T1D and celiac autoantibodies. Screening is incorporated into routine health care visits within an integrated health system.
Gender:
All
Ages:
Between 0 minutes and 17 years
Trial Updated:
04/19/2024
Locations: Sanford Bemidji Region Clinics, Bemidji, Minnesota +3 locations
Conditions: Type 1 Diabetes, Celiac Disease
Register for Updates
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
NCT01931644
Recruiting
We are the missing link in clinical trials, connecting patients and researchers seamlessly and conveniently using a mobile health platform to advance medical research. We make it easy for patients to contribute to research for medical conditions that matter most to them, regardless of their location or ability to travel.
Gender:
All
Ages:
Between 18 years and 100 years
Trial Updated:
04/15/2024
Locations: Sanguine Biosciences, Los Angeles, California
Conditions: All Diagnosed Health Conditions, ADD/ADHD, Alopecia Areata, Ankylosing Spondylitis, Asthma, Atopic Dermatitis Eczema, Beta Thalassemia, Bipolar Disorder, Breast Cancer, Celiac Disease, Cervical Cancer, Chronic Inflammatory Demyelinating Polyneuropathy, Chronic Kidney Diseases, Chronic Obstructive Pulmonary Disease, Colon Cancer, Colorectal Cancer, Crohn's Disease, Cystic Fibrosis, Depression, Diabetes Mellitus, Duchenne Muscular Dystrophy, Endometriosis, Epilepsy, Facioscapulohumeral Muscular Dystrophy, G6PD Deficiency, General Anxiety Disorder, Hepatitis B, Hereditary Hemorrhagic Telangiectasia, HIV/AIDS, Human Papilloma Virus, Huntington's Disease, Idiopathic Thrombocytopenic Purpura, Insomnia, Kidney Cancer, Leukemia, Lung Cancer, Lupus Nephritis, Lymphoma, Melanoma, Multiple Myeloma, Multiple Sclerosis, Myositis, Myotonic Dystrophy, Ovarian Cancer, Pancreatic Cancer, Parkinson's Disease, Polycystic Kidney Diseases, Prostate Cancer, Psoriasis, Psoriatic Arthritis, Rosacea, Scleroderma, Sickle Cell Anemia, Sickle Cell Trait, Sjogren's Syndrome, Skin Cancer, Spinal Muscular Atrophy, Systemic Lupus Erythematosus, Thrombotic Thrombocytopenic Purpura, Trisomy 21, Ulcerative Colitis
Register for Updates
A Study of Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of KAN-101 in Celiac Disease (ACeD-it)
NCT05574010
Recruiting
This study is to evaluate the Pharmacodynamic (PD), safety, tolerability, Pharmacokinetic (PK), and plasma biomarker response of KAN-101 in participants with Celiac Disease (CeD).
Gender:
All
Ages:
Between 18 years and 70 years
Trial Updated:
04/03/2024
Locations: University of Alabama at Birmingham, Birmingham, Alabama +27 locations
Conditions: Celiac Disease
Register for Updates
A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease
NCT06001177
Recruiting
The study goal is to evaluate the efficacy, safety, and tolerability of KAN-101 in participants with Celiac Disease (CeD)
Gender:
All
Ages:
Between 18 years and 70 years
Trial Updated:
03/04/2024
Locations: Peak Gastroenterology Associates, Colorado Springs, Colorado +3 locations
Conditions: Celiac Disease, Coeliac Disease
Register for Updates
Double Blind, Placebo-controlled Trial to Establish Safety and Efficacy of Ritlecitinib in Celiac Disease Patients in Remission
NCT05636293
Recruiting
Subjects include: aged 18 to 75 years, inclusive, have biopsy-confirmed disease that is clinically inactive as determined by negative celiac disease (CeD) serology and histology (determined via endoscopy at time of screening), have followed a gluten-free diet (GFD) for ≥6 months as reported by the subject, and be human leukocyte antigen (HLA)-DQ2.5 and/or HLA-DQ8 positive. Study involves the following randomized intervention; 10g gluten + 200mg of Ritlecitinib or placebo
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
02/26/2024
Locations: Massachusetts General Hospital, Boston, Massachusetts
Conditions: Celiac Disease
Register for Updates
Immune Responses to Gluten
NCT05209568
Recruiting
This is a study of immune responses after eating gluten powder in people with celiac disease and healthy controls.
Gender:
All
Ages:
Between 2 years and 101 years
Trial Updated:
01/11/2024
Locations: Children's Hospital Colorado, Aurora, Colorado +1 locations
Conditions: Celiac Disease, Malabsorption Syndromes, Digestive System Disease, Intestinal Disease, Gastrointestinal Diseases, Gluten Sensitivity, Celiac Disease in Children
Register for Updates
Tissue Destruction and Healing in Celiac Disease
NCT05680012
Recruiting
The purpose of this clinical study is to learn more about celiac disease pathogenesis and clinical symptoms. In particular, this study will examine the interactions between biological factors such as, intestinal epithelial cells, microbiota, immune system, genetics, and gluten and their effect on celiac disease clinical symptoms, and severity of tissue destruction and its ability to heal in individuals with celiac disease. Information collected in the study will help researchers to generate bett... Read More
Gender:
All
Ages:
Between 18 years and 70 years
Trial Updated:
12/04/2023
Locations: California Institute of Technology, Pasadena, California +2 locations
Conditions: Celiac Disease
Register for Updates
Study of the Safety, Tolerability, Pharmacokinetics and Biomarker of DONQ52 in Celiac Disease Patients
NCT05425446
Recruiting
This study is to characterize the safety and tolerability of an investigational drug called DONQ52 and consists of a single ascending dose part (Part A) and a multiple ascending dose part (Part B) in well-controlled celiac disease patients.
Gender:
All
Ages:
Between 18 years and 70 years
Trial Updated:
11/26/2023
Locations: Pinnacle Research Group, Anniston, Alabama +21 locations
Conditions: Celiac Disease
Register for Updates
Celiac Disease Genomic Environmental Microbiome and Metabolomic Study
NCT02061306
Recruiting
Celiac disease (CD) is a complex disease caused by eating gluten, a protein contained in wheat, rye, and barley. It is well known that many factors contribute to the development of CD, including the genes that you have and the foods that you eat. In the CDGEMM study, we will consider as many of these factors as possible and study how they each contribute to disease development. If the investigators find that any one factor, or combination of factors, increases the risk of developing CD, we will... Read More
Gender:
All
Ages:
6 months and below
Trial Updated:
10/31/2023
Locations: Massachusetts General Hospital for Children, Boston, Massachusetts +1 locations
Conditions: Celiac Disease
Register for Updates
T Cell Receptor (TCR) Sequencing and Transcriptional Profiling in Adult Celiac Disease Patients Undergoing Gluten Challenge
NCT04614571
Recruiting
The primary objectives are: Characterize the T cell receptor (TCR) repertoire in duodenal biopsy samples of participants pre- and post-challenge. Compare for each patient the TCR repertoire of duodenal biopsy samples with the peripheral blood TCR repertoire of each study participant Characterize the transcriptome of duodenal biopsy samples and blood from study participants pre- and post-challenge The secondary objectives are: Ex vivo identification and validation of DQ-restricted gliadin spec... Read More
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
09/11/2023
Locations: Celiac Research Centre Mass General Hospital, Boston, Massachusetts
Conditions: Celiac Disease
Register for Updates
Celiac Disease Database
NCT01172665
Recruiting
The focus of this study is to create a database containing information about patients with celiac disease. This database will allow us to examine clinical and epidemiologic features of the University of Chicago Medical Center patient population. We have the largest population of patients with celiac disease in the mid-West and as such this study using information gathered from our database can greatly contribute to our current understanding of this disease.
Gender:
All
Ages:
Between 0 years and 70 years
Trial Updated:
06/01/2023
Locations: The University of Chicago Medical Center, Chicago, Illinois
Conditions: Celiac Disease
Register for Updates
Bovine Colostrum to Prevent Absorption of Gluten
NCT05555446
Recruiting
To investigate the use of hyperimmune bovine colostrum to reduce gluten absorption. A double-blind, cross-over study will be performed in which persons who are following a strict gluten-free diet will be challenged with oral gluten with or without the bovine colostrum.
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
05/22/2023
Locations: Beth Israel Deaconess Medical Center, Boston, Massachusetts
Conditions: Celiac Disease, Gluten Sensitivity, Non-celiac Gluten Sensitivity
Register for Updates